More articles about: Cardiovascular: Preventive Cardiology

Cholesterol-lowering medicines called statins can reduce heart attack and stroke risk decades later; a study finds millions more people should be taking them.

A baby boy born with a severe form of hypertrophic cardiomyopathy needed a complicated procedure few centers perform

This article features experts from Michigan Medicine as part of a month-long effort to raise awareness about heart disease and empower people to protect their heart health. 

Newborn with a complex congenital heart defect receives coordinated, specialty care close to home while gaining strength before surgery.

A step-by-step guide on how to use an automated external defibrillator, or AED in a cardiac arrest or emergency

National poll suggests many schools, families and communities may not be fully prepared to respond to cardiac emergencies in teens.

Once revived after a sudden cardiac arrest at soccer practice as a teenager, a woman returns to the same care team more than a decade later to safely grow her family.

A Michigan Medicine electrophysiologist discusses heart arrhythmia, sharing what signs to look for and when to see your doctor.

Michigan Medicine researchers found that by collecting genetic information and clinical data from an individual patient can help predict their heart failure risk a decade before it’s diagnosed.

A multidisciplinary team at Michigan Medicine answers important questions about peripheral artery disease, also known as PAD.

A doctor talks about key facts and insight about congestive heart failure.

Despite the success cardiac rehabilitation has shown at reducing heart-related deaths and hospital readmissions, higher out-of-pocket costs may prevent patients from participating in the program, a University of Michigan study suggests. 

For people taking the popular blood thinners rivaroxaban (brand name Xarelto) and apixaban (brand name Eliquis), after having a blood clot, a reduced dose may limit the future risk of bleeding as well as hospital visits, a Michigan Medicine-led study suggests.

Wegovy (semaglutide) now has Medicare approval for coverage among people with obesity and cardiovascular disease but no diabetes; a study looks at what level of risk might make someone eligible.

Doctors and pharmacists treating people with blood thinners can now reduce the rate of inappropriate dosing — as well as blood clots and strokes that can result from it — using an electronic patient management system.